![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Grants Priority Review for Nexavar in Thyroid Cancer
FDA Grants Priority Review for Nexavar in Thyroid Cancer
August 28, 2013
The FDA has granted Nexavar, a collaboration between Onyx and Bayer, priority review status, placing the drug a step closer to being approved to treat thyroid cancer.
Pharma Times
Pharma Times
Upcoming Events
-
21Oct